You need to log in as a subscriber to access this page.

Study finds leukotoxins are main BRD concern

Dec 20, 2007
November 26, 2007 A new study conducted under feedlot conditions demonstrates that, despite improvements made in the quality of commercial vaccines against the bacterium Mannheimia haemolytica, those that don’t include a component to specifically stimulate protection against leukotoxin risk failure. Leukotoxin is a natural byproduct produced by infection with M. haemolytica. Believed to be only one of the pathogenic factors M. haemolytica produces&...

You must Sign In or Register to access this content

Not a subscriber yet? Try WLJ free for 30 days!

Register to read WLJ's digital edition and enjoy unlimited access to the news source more livestock producers depend on.

Click here to begin your free 30 day trial subscription.

Current Users


Forget your password?
Subscribe

Current WLJ subscribers: Log in using your six-digit customer number, which you will find printed above your name on the mailing label of your weekly journal. Use the password wlj123, then go to the profile page to customize your password and log in as you wish.

Sales Calendar